Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

CLINICAL USE OF SULFAMETHYLTHIAZOLE

CLINICAL USE OF SULFAMETHYLTHIAZOLE Abstract Since the introduction of chemotherapeutic agents effective in the treatment of streptococcic and pneumococcic infections, efforts have been made to improve on these agents and to develop a compound equally effective against infections caused by staphylococci. Sulfathiazole (2-sulfanilamidothiazole) and sulfamethylthiazole (2-sulfanilamido-4-methylthiazole) have shown promise in this direction. Sulfamethylthiazole is a white amorphous powder which is less soluble than sulfanilamide, sulfapyridine or sulfathiazole. Sulfamethylthiazole (together with sulfathiazole) was first synthesized in August 1939 by Fosbinder and Walter,1 who also reported its effectiveness against streptococci and pneumococci. Lawrence2 found sulfathiazole and sulfamethylthiazole to be superior to sulfanilamide in their bacteriostatic effect against Lancefield group A Streptococcus haemolyticus and against the colon-typhoid-dysentery group. Barlow and Homburger3 reported that in experimentally produced infections with Str. haemolyticus and Pneumococcus types I, II and III the effect of thiazole derivatives of sulfanilamide was definitely superior to that of the parent substance and compared References 1. Fosbinder, R. F., and Walter, L. A.: Sulfanilamido Derivatives of Heterocyclic Amines , J. Am. Chem. Soc. 61:2032, 1939.Crossref 2. Lawrence, C. A.: Bacteriologic Actions of Three Thiazol Derivatives of Sulfanilamide upon Bacteria in Broth Cultures , Proc. Soc. Exper. Biol. & Med. 43:92, 1940 3. Bacteriostatic Effects of Sulfanilamide, Sulfapyridine and the Thiazol Derivatives, in Colon-Typhoid-Dysentery Group , Lawrence Proc. Soc. Exper. Biol. & Med. 44:162, 1940. 4. Barlow, O. W., and Homburger, E.: Thiazol Derivatives of Sulfanilamide and Effect on Beta-Hemolytic Streptococcus and Pneumococcus Infections in Mice , Proc. Soc. Exper. Biol. & Med. 43:317, 1940 5. Specific Chemotherapy of Experimental Staphylococcus Infections with Thiazol Derivatives of Sulfanilamide , Barlow Proc. Soc. Exper. Biol. & Med. 42:792, 1939. 6. Weilbaecher, J. O., Jr.; Moss, E. S.; Taylor, H. M., and Dupuy, H.: Treatment of Typhoid Fever with Thiazole Derivatives of Sulfanilamide: Preliminary Report of Four Cases , South. M. J. 33:645, 1940. 7. Carroll, G., and others: Sulfamethylthiazole: Report of Its Clinical Use in Staphylococcus Septicemia with Apparent Success , South. M. J. 33:83, 1940. 8. Grulee, C. G., and Mason, J. T.: New Treatment of Furunculosis (Sulfamethylthiazol) , J. Pediat. 15:549 ( (May) ) 1940. 9. Herrell, W. E., and Brown, A. E.: The Clinical Use of Sulfamethylthiazole in Infections Caused by Staphylococcus Aureus: Preliminary Report , Proc. Staff Meet., Mayo Clin. 14:753, 1939. 10. The drug was supplied by the Lederle Laboratories, Inc., and the Winthrop Chemical Co., Inc. 11. Kolmer, J. A.: Progress in Chemotherapy of Bacterial and Other Diseases with Special Reference to the Prontosils, Sulfanilamide and Sulfapyridine , Arch. Int. Med. 65:671 ( (April) ) 1940. 12. Baker, L. D., and Shands, A. R., Jr.: Acute Osteomyelitis with Staphylococcemia , J. A. M. A. 113:2119 ( (Dec. 9) ) 1939. 13. The Winthrop Chemical Co., Inc. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Internal Medicine American Medical Association

Loading next page...
 
/lp/american-medical-association/clinical-use-of-sulfamethylthiazole-MqhH250tIh

References (13)

Publisher
American Medical Association
Copyright
Copyright © 1941 American Medical Association. All Rights Reserved.
ISSN
0730-188X
DOI
10.1001/archinte.1941.00200040148011
Publisher site
See Article on Publisher Site

Abstract

Abstract Since the introduction of chemotherapeutic agents effective in the treatment of streptococcic and pneumococcic infections, efforts have been made to improve on these agents and to develop a compound equally effective against infections caused by staphylococci. Sulfathiazole (2-sulfanilamidothiazole) and sulfamethylthiazole (2-sulfanilamido-4-methylthiazole) have shown promise in this direction. Sulfamethylthiazole is a white amorphous powder which is less soluble than sulfanilamide, sulfapyridine or sulfathiazole. Sulfamethylthiazole (together with sulfathiazole) was first synthesized in August 1939 by Fosbinder and Walter,1 who also reported its effectiveness against streptococci and pneumococci. Lawrence2 found sulfathiazole and sulfamethylthiazole to be superior to sulfanilamide in their bacteriostatic effect against Lancefield group A Streptococcus haemolyticus and against the colon-typhoid-dysentery group. Barlow and Homburger3 reported that in experimentally produced infections with Str. haemolyticus and Pneumococcus types I, II and III the effect of thiazole derivatives of sulfanilamide was definitely superior to that of the parent substance and compared References 1. Fosbinder, R. F., and Walter, L. A.: Sulfanilamido Derivatives of Heterocyclic Amines , J. Am. Chem. Soc. 61:2032, 1939.Crossref 2. Lawrence, C. A.: Bacteriologic Actions of Three Thiazol Derivatives of Sulfanilamide upon Bacteria in Broth Cultures , Proc. Soc. Exper. Biol. & Med. 43:92, 1940 3. Bacteriostatic Effects of Sulfanilamide, Sulfapyridine and the Thiazol Derivatives, in Colon-Typhoid-Dysentery Group , Lawrence Proc. Soc. Exper. Biol. & Med. 44:162, 1940. 4. Barlow, O. W., and Homburger, E.: Thiazol Derivatives of Sulfanilamide and Effect on Beta-Hemolytic Streptococcus and Pneumococcus Infections in Mice , Proc. Soc. Exper. Biol. & Med. 43:317, 1940 5. Specific Chemotherapy of Experimental Staphylococcus Infections with Thiazol Derivatives of Sulfanilamide , Barlow Proc. Soc. Exper. Biol. & Med. 42:792, 1939. 6. Weilbaecher, J. O., Jr.; Moss, E. S.; Taylor, H. M., and Dupuy, H.: Treatment of Typhoid Fever with Thiazole Derivatives of Sulfanilamide: Preliminary Report of Four Cases , South. M. J. 33:645, 1940. 7. Carroll, G., and others: Sulfamethylthiazole: Report of Its Clinical Use in Staphylococcus Septicemia with Apparent Success , South. M. J. 33:83, 1940. 8. Grulee, C. G., and Mason, J. T.: New Treatment of Furunculosis (Sulfamethylthiazol) , J. Pediat. 15:549 ( (May) ) 1940. 9. Herrell, W. E., and Brown, A. E.: The Clinical Use of Sulfamethylthiazole in Infections Caused by Staphylococcus Aureus: Preliminary Report , Proc. Staff Meet., Mayo Clin. 14:753, 1939. 10. The drug was supplied by the Lederle Laboratories, Inc., and the Winthrop Chemical Co., Inc. 11. Kolmer, J. A.: Progress in Chemotherapy of Bacterial and Other Diseases with Special Reference to the Prontosils, Sulfanilamide and Sulfapyridine , Arch. Int. Med. 65:671 ( (April) ) 1940. 12. Baker, L. D., and Shands, A. R., Jr.: Acute Osteomyelitis with Staphylococcemia , J. A. M. A. 113:2119 ( (Dec. 9) ) 1939. 13. The Winthrop Chemical Co., Inc.

Journal

Archives of Internal MedicineAmerican Medical Association

Published: Apr 1, 1941

There are no references for this article.